| Income Statement |
| Total Revenue | 6.11M |
|
| Revenues (USD) | 6.11M |
| Cost of Revenue | 1.45M |
| Gross Profit | 4.66M |
| Operating Expenses | 11.02M |
| Research and Development Expense | 3.08M |
| Selling, General and Administrative Expense | 6.55M |
| Operating Income | -6.36M |
| Income Tax Expense | 40.00K |
| Net Income | -118.30M |
| Net Income Common Stock | -118.30M |
| Net Income Common Stock (USD) | -118.30M |
| Consolidated Income | -118.30M |
| Earnings per Basic Share | -0.84 |
| Earnings per Basic Share (USD) | -0.84 |
| Earnings per Diluted Share | -0.84 |
| Earning Before Interest & Taxes (EBIT) | -118.26M |
| Earning Before Interest & Taxes (USD) | -118.26M |
| Weighted Average Shares | 140.94M |
| Weighted Average Shares Diluted | 140.94M |
| Balance Sheet |
| Cash and Equivalents | 128.95M |
| Cash and Equivalents (USD) | 128.95M |
| Trade and Non-Trade Receivables | 9.96M |
| Current Assets | 144.53M |
| Property, Plant & Equipment Net | 35.73M |
| Total Assets | 188.06M |
| Debt Current | 1.34M |
| Total Debt | 149.71M |
| Current Liabilities | 59.11M |
| Debt Non-Current | 148.37M |
| Total Liabilities | 213.59M |
| Accumulated Retained Earnings (Deficit) | -523.19M |
| Accumulated Other Comprehensive Income | -2.00K |
| Shareholders Equity | -25.53M |
| Shareholders Equity (USD) | -25.53M |
| Assets Non-Current | 43.54M |
| Total Debt (USD) | 149.71M |
| Deferred Revenue | 20.98M |
| Inventory | 2.36M |
| Liabilities Non-Current | 154.48M |
| Trade and Non-Trade Payables | 3.75M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.90M |
| Net Cash Flow from Financing | 32.50M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 27.11M |
| Capital Expenditure | -5.55M |
| Issuance (Purchase) of Equity Shares | 32.81M |
| Net Cash Flow from Investing | -5.55M |
| Net Cash Flow from Operations | 158.00K |
| Effect of Exchange Rate Changes on Cash | -2.00K |
| Share Based Compensation | 735.00K |